Annette Schmid, PhD, is a Sr Director Global Science Policy at Takeda where she focusses on policies related to biospecimen, data, AI and innovative scientific approaches in clinical trials. She has 25+ years of experience as a scientist in academia and industry, co-founded the
Science Policy Think Tank, has lead a number of industry fora, including
PINTAD and
GBITR and has been part of the
QIBA steering committee and
FNIH working groups with a particular interest in seeing appropriate innovation and industry consensus in clinical trial endpoints for novel treatments. Prior to her career in science, she worked for the German State Department mostly in cultural and legal affairs.